Kiora Pharmaceuticals, Inc.
KPRX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $11 | $13 | $10 |
| - Cash | $6 | $1 | $4 | $4 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | – | $11 | $9 | $6 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$1 | -$2 | -$2 | -$2 |
| % Margin | – | – | – | – |
| Net Income | $0 | -$2 | -$2 | -$4 |
| % Margin | – | – | – | – |
| EPS Diluted | 0.01 | -0.54 | -0.52 | -1.41 |
| % Growth | 101.9% | -3.8% | 63.1% | – |
| Operating Cash Flow | -$1 | -$4 | -$3 | -$2 |
| Capital Expenditures | -$0 | -$0 | $0 | $0 |
| Free Cash Flow | -$1 | -$4 | -$3 | -$2 |